TerrAscend (TSNDF) Retained Earnings (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Retained Earnings of -$873.8 million for Q1 2026, down 10.32% year-over-year from -$974.3 million in Q1 2025, and down 191.0% quarter-over-quarter from $960.2 million in Q4 2025.
TerrAscend (TSNDF) Retained Earnings (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Retained Earnings for 6 consecutive years, with -$873.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 10.32% year-over-year to -$873.8 million; the TTM figure through Mar 2026 stood at -$873.8 million (down 10.32% YoY), while the FY2025 annual figure was $960.2 million, up 31791.1% from the prior year.
- Retained Earnings eased to -$873.8 million in Q1 2026 per TSNDF's latest filing, from $960.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $960.2 million in Q4 2025 and bottomed at -$873.8 million in Q1 2026.
- Historically, Retained Earnings has averaged $84.7 million across 5 years, with a median of $1.7 million in 2023.
- On a YoY basis, Retained Earnings climbed as much as 54320.31% in 2024 and fell as far as 46476.71% in 2024.
- TerrAscend's Retained Earnings stood at -$618.3 million in 2022, then soared by 252.83% to $944.9 million in 2023, then sank by 99.68% to $3.0 million in 2024, then surged by 31791.1% to $960.2 million in 2025, then slumped by 191.0% to -$873.8 million in 2026.
- Business Quant data shows TSNDF's Retained Earnings at -$873.8 million in Q1 2026, $960.2 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 959.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 959.97 Mn |
| Mar 31, 2026 | -873.80 Mn |
| Dec 31, 2025 | 960.24 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -841.47 Mn |
| Mar 31, 2025 | -792.09 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | -746.67 Mn |
| Jun 30, 2024 | 945.80 Mn |
| Mar 31, 2024 | 945.83 Mn |
| Dec 31, 2023 | 944.86 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 945.93 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | -618.26 Mn |
| Sep 30, 2022 | 877.30 Mn |
| Jun 30, 2022 | -315.13 Mn |
| Mar 31, 2022 | -783,000.00 |
| Dec 31, 2021 | 535.42 Mn |